glp 1 drug novo nordisk launches Wegovy weight-loss pill in US, triggering price war | Pharmaceuticals industry Novo Nordisk Finds Medicare Patients

This consensus paper aims to provide guidance on the utilization of DPP-4 inhibitors in T2DM management from an Indian perspective

The findings suggest AI could turn social media into a powerful early-warning system for spotting side effects that clinical trials may miss.

A comprehensive literature search was conducted across the PubMed, Embase, and Google Scholar databases for peer-reviewed articles published from inception through June 15, 2026, focusing on the landmark SURPASS, SURMOUNT, and SUMMIT trial programs, relevant cardiorenal post hoc analyses, emerging body recomposition trials, and real-world cohort-switching protocols

Semaglutide subcutaneous and dulaglutide reduced stroke cases